Results 31 to 40 of about 86,717,132 (169)
In 2022, the Food and Drug Administration approved a second mitral transcatheter edge-to-edge repair device for the treatment of primary mitral regurgitation (PASCAL Precision Transcatheter Valve Repair System, Edwards Lifesciences, Irvine, CA).
Santiago Garcia, MD +8 more
doaj +1 more source
The challenges of bioprosthetic heart valves (BHV) with respect to calcification, infection, and poor durability are tackled by surface engineering of hyperbranched poly‐L‐lysine (HBPL), providing a translational solution to improve long‐term valve performance.
Pai Peng +7 more
wiley +1 more source
Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß +14 more
wiley +1 more source
Edge-to-Edge Repair of the Mitral Valve with the Mitraclip System: Evolution of Leaflet Grasping ...
G. Burkhard Mackensen (6795905) +1 more
core +1 more source
Transcatheter structural heart procedures, including transcatheter aortic valve replacement (TAVR) and transcatheter edge-to-edge repair (TEER), have revolutionized the management of valvular heart diseases in selected or high-risk patients [...]
Antonio Nenna +3 more
doaj +1 more source
Torrential Mitral Regurgitation After Transcatheter Edge-to-Edge Mitral Valve Repair
A patient with severe mitral regurgitation and chronic systolic heart failure taking inotropic support at home presents for transcatheter edge-to-edge mitral valve repair, complicated by torrential mitral regurgitation from damaged mitral leaflets ...
Jonathan Blossom, MD +9 more
doaj +1 more source
Interventional Mitral Valve Edge‐to‐Edge Repair in Patients Above 85 Years of Age
ABSTRACT Background Mitral valve transcatheter‐edge‐to‐edge repair (M‐TEER) is routinely performed in patients with severe mitral regurgitation (MR) at high operative risk, frequently including elderly patients. Patients ≥ 85 years, however, are frequently excluded in clinical studies.
Florian Jürgens +8 more
wiley +1 more source
DOI: 10.1016/j.echo.2021.01.010 Fluoroscopic-echocardiographic fusion imaging (FI) is able to acquire imaging data from both fluoroscopy and transesophageal images and co-register and align them in the 3D space and time by putting onto the same ...
Agricola, Eustachio
core +1 more source
Three-Dimensional Intracardiac Echocardiography for Tricuspid Transcatheter Edge-to-Edge Repair
Patients with severe symptomatic tricuspid regurgitation face a significant dilemma in treatment options, as the yearly mortality with medical therapy and the surgical mortality for tricuspid repair or replacement are high.
Scott M. Chadderdon, MD +21 more
doaj +1 more source
Successful Percutaneous Retrieval of an Embolized MitraClip From the Right Subclavian Artery
ABSTRACT Single leaflet device attachment (SLDA) after mitral transcatheter valve edge‐to‐edge repair (M‐TEER) has been reported in up to 5% of patients. However, complete embolization of the M‐TEER device is exceedingly rare. Device retrievals in all previously reported cases were completed by vascular surgery cut down at the end. In this case, we are
Seyed Hossein Aalaei‐Andabili +2 more
wiley +1 more source

